7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

CARGO Therapeutics Inc
(NASDAQ:CRGX) 

CRGX stock logo

CARGO Therapeutics, Inc., a clinical-stage biotechnology company, develops chimeric antigen receptor T-cell therapies for cancer patients.

Founded: 2019
Sector: TECHNOLOGY
Industry: GENERAL

Share this website to your friends
CARGO Therapeutics Op Cashflow Per Share ttm
202311 202312 202401 202402 202403 202404 -1.64-1.41-1.17-0.94-0.7-0.47-0.230
CARGO Therapeutics Free Cashflow Per Share ttm
202311 202312 202401 202402 202403 202404 -1.85-1.58-1.32-1.06-0.79-0.53-0.26-0
CARGO Therapeutics Cash Per Share ttm
202311 202312 202401 202402 202403 202404 01.534.567.498.9910.49
CARGO Therapeutics (GAAP) P/E ratio ttm
202311 202312 202401 202402 202403 202404 -19.7-16.88-14.07-11.26-8.44-5.63-2.810
CARGO Therapeutics P/B ratio ttm
202311 202312 202401 202402 202403 202404 -8.87-7.31-5.75-4.19-2.63-1.070.492.05
No extra charts and metrics for this ticker.